It is early in the game but here's what traders can do.
The medical device and health care company is set to resume its long advance, with our first price target at $92 and next at $100.
After correction, the medical device maker could see longer-term gains to the $150-$161 area.
If you are not already long EW or just want to add to longs you should use any minor intraday dip today or tomorrow to buy.
Let's review the charts and indicators of ISRG.
PETS has generated positive operating cash flow for more than a decade and it has been using that cash flow to pay dividends to shareholders.
Traders and investors can approach TNDM from the long side.
These names should benefit from the aging of the population and the increasing use of medical and healthcare facilities.
The aging population is creating a massive tailwind for companies that provide cutting-edge health care.
The most important thing to remember about trading earnings is that you do not have to hold a stock into its report in order to find good trade entries.